A conserved matrix-centred core links fibrosis across human organs and mouse models
Fibrosis develops in many organs through different initiating injuries, yet repeatedly engages inflammation, stromal activation and extracellular-matrix remodelling. Whether these recurring features represent a conserved disease programme, and whether commonly used mouse models reproduce it, remain unresolved. We developed ScarX, an R/Shiny workflow that analyses organ-resolved bulk RNA sequencing, identifies directional overlap across tissues, and ranks human-mouse conserved signals while retaining organ-restricted results. Public RNA-sequencing datasets representing fibrotic or fibrosis-associated disease in human heart, kidney, liver and lung were compared with matched mouse injury models. Differential expression was estimated independently within each organ using DESeq2, followed by cross-organ intersection, functional enrichment, matched-organ effect-profile comparison and a human-first conserved modulation (HCM) score that gives greatest weight to the breadth and magnitude of human disease change, adds support for same-direction mouse effects and penalises discordance. In human disease, 202 genes increased and 35 decreased in the same direction across all four organs. Mouse models contained 409 pan-organ increases and 46 decreases. After gene-symbol harmonisation, 25 gene-direction signatures were conserved across all four organs in both species. These included AEBP1, CDH11, COL1A1, COL1A2, COL3A1, COL5A2, COL6A2, EFEMP2, EMILIN1, LOXL1, LOXL2, TGFB2 and VIM. Matched human-mouse effect profiles varied considerably: Spearman rho was 0.42 for kidney, 0.31 for heart, 0.16 for liver and -0.06 for lung. Despite this uneven gene-level fidelity, 62 same-direction pathways were shared across species, led by extracellular-matrix organisation, collagen fibril organisation, cell-substrate adhesion, wound healing and ECM-receptor interaction. The HCM ranking concentrated structural matrix genes near the top but also identified cell-surface, secreted and regulatory candidates. Among the top 500 candidates, 376 carried at least one local tractability annotation. ScarX therefore separates a compact conserved matrix-remodelling core from a much larger organ- and species-dependent response. The results provide a transparent starting point for target and biomarker selection, while also showing why expression conservation alone cannot establish therapeutic dependence.
Authors
- Katie J. Mylonas (ORCID: https://orcid.org/0000-0002-7324-4597)
- Samuele Di Carmine (ORCID: https://orcid.org/0000-0001-8419-8832)
- Richard Cunningham
Institutions
- Centre for Inflammation Research (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-16
- DOI
- https://doi.org/10.64898/2026.11.13.766356
- Primary Topic
- Liver physiology and pathology
- Type
- preprint
Funders
- Kidney Research UK
- Academy of Medical Sciences